Stoke Therapeutics reported total assets of $393.97M and total liabilities of $48.42M for the quarter ended Jun 2026, up 2.5% year over year. This balance sheet covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 149.04M | 144.90M | 84.11M | 67.75M | 113.40M | 113.56M | 190.34M | 192.06M | 189.98M | 191.44M | 178.58M | 193.48M | 150.02M | 127.98M | 274.82M | 101.47M | 83.39M | 84.22M | 155.66M | 110.00M | |||||||||||||
| Short-term InvestmentsInvestments (Current) | 87.12M | 74.92M | 209.10M | 207.88M | 138.26M | 116.04M | 63.33M | 39.39M | 24.74M | 9.95M | 0.07M | 0.07M | 88.92M | 82.51M | 146.24M | 164.92M | 200.45M | 187.89M | 182.81M | ||||||||||||||
| Cash & Current Investments | 236.16M | 219.81M | 293.22M | 275.63M | 251.66M | 229.59M | 253.67M | 231.45M | 214.72M | 201.39M | 178.58M | 193.55M | 150.09M | 216.90M | 357.32M | 247.71M | 248.31M | 284.67M | 343.55M | 292.82M | |||||||||||||
| Receivables - NetNet Receivables | 1.67M | 9.25M | 5.94M | 4.45M | 7.18M | ||||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.04M | 0.13M | 0.27M | 0.35M | 0.40M | 0.59M | 0.49M | 0.14M | 0.10M | 0.06M | 0.01M | 0.30M | 0.69M | 0.70M | 0.61M | 1.62M | 1.59M | 1.97M | 1.69M | 1.54M | |||||||||||||
| Receivables | 2.37M | 10.84M | 7.91M | 6.14M | 8.72M | ||||||||||||||||||||||||||||
| Prepaid Assets | 8.47M | 6.94M | 12.29M | 13.18M | 12.55M | 10.93M | 10.19M | 10.95M | 10.94M | 11.32M | 10.72M | 10.35M | 9.84M | 11.12M | 12.69M | 13.69M | 7.75M | 8.74M | 10.12M | 14.69M | |||||||||||||
| Current Assets | 244.93M | 229.22M | 305.77M | 289.16M | 264.60M | 244.07M | 270.24M | 246.23M | 230.02M | 215.34M | 193.28M | 296.99M | 253.61M | 232.76M | 375.74M | 269.97M | 272.44M | 305.70M | 366.68M | 322.54M | |||||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 2.94M | 4.14M | 5.04M | 5.87M | 7.16M | 6.67M | 6.79M | 6.47M | 6.22M | 5.82M | 5.28M | 4.77M | 4.33M | 3.91M | 3.61M | 3.34M | 3.08M | 3.15M | 3.40M | 4.83M | |||||||||||||
| Long-Term Investments | 29.95M | 29.82M | 22.99M | 107.26M | 80.31M | 106.26M | 67.48M | 61.50M | |||||||||||||||||||||||||
| Long-Term Deferred Tax | 66.00M | ||||||||||||||||||||||||||||||||
| Other Non-Current Assets | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.57M | 0.49M | 0.49M | 0.72M | 0.72M | 0.72M | 0.72M | 0.23M | 3.23M | 3.23M | |||||||||||||
| Non-Current Assets | 8.84M | 9.65M | 10.17M | 12.27M | 13.03M | 12.00M | 11.56M | 10.69M | 9.87M | 13.00M | 11.91M | 10.76M | 39.71M | 38.80M | 31.15M | 114.54M | 87.83M | 112.73M | 76.60M | 71.43M | |||||||||||||
| Assets | 253.77M | 238.87M | 315.94M | 301.43M | 277.63M | 256.07M | 281.80M | 256.92M | 239.89M | 228.34M | 205.18M | 307.76M | 293.32M | 271.56M | 406.89M | 384.51M | 360.26M | 418.43M | 443.28M | 393.97M | |||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||||
| Accounts Payables | 0.66M | 2.38M | 3.33M | 3.60M | 1.91M | 0.77M | 4.30M | 1.56M | 3.08M | 1.70M | 2.10M | 3.94M | 2.48M | 2.50M | 2.19M | 4.31M | 5.87M | 4.94M | 6.84M | 4.79M | |||||||||||||
| Payables | 0.66M | 2.38M | 3.33M | 3.60M | 1.91M | 0.77M | 4.30M | 1.56M | 3.08M | 1.70M | 2.10M | 3.94M | 2.48M | 2.50M | 2.19M | 4.31M | 5.87M | 4.94M | 6.84M | 4.79M | |||||||||||||
| Accumulated Expenses | 11.23M | 14.75M | 11.11M | 13.41M | 14.05M | 15.75M | 13.78M | 12.22M | 13.39M | 13.81M | 12.57M | 14.50M | 15.77M | 18.57M | 24.34M | 25.62M | 30.09M | 41.03M | 23.90M | 28.61M | |||||||||||||
| Other Accumulated Expenses | 0.33M | 0.54M | 0.52M | 0.75M | 0.43M | 0.51M | 0.51M | 0.70M | 0.47M | 0.86M | 0.98M | 1.04M | 0.60M | 0.75M | 2.07M | 1.75M | 0.80M | 1.06M | 1.50M | 1.62M | |||||||||||||
| Current Deferred Revenue | 8.47M | 10.63M | 12.84M | 14.88M | 13.45M | 8.06M | 8.73M | 15.31M | 20.92M | 26.05M | 31.61M | 18.99M | 18.16M | 8.75M | 5.76M | 11.90M | 10.07M | 8.52M | |||||||||||||||
| Total Current Liabilities | 11.88M | 17.14M | 22.91M | 27.65M | 28.80M | 31.39M | 31.53M | 21.84M | 25.20M | 30.82M | 35.59M | 44.50M | 49.87M | 40.06M | 44.69M | 38.68M | 41.73M | 57.88M | 40.81M | 41.93M | |||||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||||
| Non-Current Deffered Revenue | 49.55M | 45.21M | 41.08M | 36.86M | 34.14M | 43.26M | 40.73M | 33.07M | 25.04M | 16.95M | 8.29M | 10.26M | 9.63M | 8.56M | 6.96M | 6.60M | 5.65M | ||||||||||||||||
| Other Non-Current Liabilities | 3.95M | 3.51M | 4.25M | 3.61M | 2.97M | 2.30M | 1.63M | 0.96M | 4.88M | 4.21M | 3.61M | 3.05M | 2.48M | 1.87M | 1.25M | 1.87M | 1.14M | 0.99M | 0.84M | ||||||||||||||
| Total Non-Current Liabilities | 4.37M | 3.95M | 53.06M | 49.46M | 44.69M | 39.82M | 36.45M | 44.89M | 41.69M | 37.96M | 29.25M | 20.55M | 11.34M | 2.48M | 12.13M | 10.89M | 10.43M | 8.10M | 7.59M | 6.49M | |||||||||||||
| Total Liabilities | 16.26M | 21.09M | 75.96M | 77.11M | 73.48M | 71.22M | 67.97M | 66.72M | 66.89M | 68.78M | 64.84M | 65.05M | 61.21M | 42.53M | 56.81M | 49.56M | 52.16M | 65.98M | 48.40M | 48.42M | |||||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||||
| Common Equity | 237.51M | 217.78M | 239.98M | 224.32M | 204.14M | 184.85M | 213.82M | 190.19M | 173.00M | 159.56M | 140.34M | 242.71M | 232.11M | 229.02M | 350.07M | 334.94M | 308.11M | 352.46M | 394.88M | 345.55M | |||||||||||||
| Liabilities and Shareholders Equity | 253.77M | 238.87M | 315.94M | 301.43M | 277.63M | 256.07M | 281.80M | 256.92M | 239.89M | 228.34M | 205.18M | 307.76M | 293.32M | 271.56M | 406.89M | 384.51M | 360.26M | 418.43M | 443.28M | 393.97M | |||||||||||||
| Retained Earnings | 409.17M | 414.02M | 461.39M | 470.98M | 477.34M | 483.17M | 534.11M | 540.92M | 548.03M | 561.43M | 568.56M | 696.64M | 712.29M | 720.00M | 728.12M | 736.28M | 747.43M | 849.62M | 942.70M | 955.42M | |||||||||||||
| Preferred Shares |